Hepatitis C vaccine: supply and demand (Q34011890)

30 July 2017

Hepatitis C vaccine: supply and demand. (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

3

Paul Klenerman

1 reference

30 July 2017

G Thomas Strickland

1

1 reference

30 July 2017

Samer S El-Kamary

series ordinal

2

1 reference

30 July 2017

Alfredo Nicosia

series ordinal

4

1 reference

30 July 2017

1 June 2008

1 reference

Lancet Infectious Diseases

30 July 2017

1 reference

30 July 2017

8

1 reference

30 July 2017

379-386

1 reference

30 July 2017

6

1 reference

Hepatitis C virus infection

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Discovery of non-A, non-B hepatitis and identification of its etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

High prevalence of hepatitis C in Egyptian patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Treating viral hepatitis C: efficacy, side effects, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

HCV-HIV coinfection: simple messages from a complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Risk factors for hepatitis C virus infection among blood donors in northern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

T cells and viral persistence: lessons from diverse infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Maternal antibodies, childhood infections, and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Genetic diversity and evolution of hepatitis C virus--15 years on

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Immunopathogenesis of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Protection against persistence of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Cross-genotype immunity to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Flying under the radar: the immunobiology of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

An HIV vaccine--evolving concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

1 reference

7 January 2021

Prospects for a vaccine against the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Viral Hepatitis in Health Care Personnel at The Johns Hopkins Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Risk of hepatitis C seroconversion after occupational exposures in health care workers*1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Role of hepatitis C infection in chronic liver disease in Egypt.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C-prevalent population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Hepatitis B epidemiology in Asia, the Middle East and Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Changing patterns of acute viral hepatitis at a major urban referral center in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990-2000).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Intrafamilial transmission of hepatitis C in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Transmission of hepatitis C virus between parents and children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970126-9

7 January 2021

10.1016/S1473-3099(08)70126-9

Identifiers

DOI

1 reference

release_sb3r5jrjqndhxkaor7lio5nlni

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sb3r5jrjqndhxkaor7lio5nlni

24 November 2022

mapped directly with Wikidata item

1 reference